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ABSTRACT
Leptospirosis has a wide range of presentation which ranges from mild flu-like symptoms, to severe form including 
renal failure, liver failure, and hemorrhage. Pulmonary involvement can progress from subtle clinical features to life 
threatening pulmonary hemorrhage and acute respiratory distress syndrome.  Although benefits of corticosteroids in 
adult respiratory distress syndrome have been proven and accepted, evidence for use of corticosteroids in pulmonary 
leptospirosis is still limited. Given the vasculitic nature of severe leptospirosis, it has been proposed that addition of 
intravenous corticosteroid therapy, particularly in cases of pulmonary involvement is beneficial. We report a case of 
leptospirosis with suspected pulmonary hemorrhage which deteriorates after a few days of admission in our tertiary 
hospital. We have demonstrated that the prescription of a lower dose of corticosteroid than what was widely reported 
in the literature can equally led to a satisfactory recovery of the pulmonary hemorrhage.
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INTRODUCTION
Leptospirosis, known to be a zoonotic disease, is 
caused by pathogenic spirochetes of genus Leptospira, 
which occurs in both temperate and tropical regions. 
Human transmission is usually through exposure of 
abraded skin or mucous membranes to fresh water or 
soil contaminated with the urine of an animal that is a 
chronic carrier. Patients can present with predominant 
pulmonary symptoms, ranging from breathlessness, 
cough, hemoptysis, and chest pain to acute respiratory 
distress syndrome (ARDS). These frequently happen 
during fourth to sixth days of illness. 
The exact cause of pulmonary hemorrhage is still 
debatable. Toxin medicated process induces vascular 
injury causing vasculitis have been proposed to be the 
main causative factor in the pathogenesis of leptospirosis. 
This vascular injury primarily affects capillaries. It is 
found that linear deposition of immunoglobulins like 
IgA, IgM and IgG and complements on the alveolar 
surface may be part of the pathogenesis of LPHS.
The administration of intravenous methylprednisolone 
in a severely ill patient with LPHS is based on the 
immune mediated pathogenesis of the disease which 
can potentially decrease the morbidity and mortality. 
Hence, early administration of methylprednisolone in 
Leptospirosis pulmonary hemorrhage syndrome has 
been proposed as part of the treatment plan.
CASE REPORT
A twenty-two-year old gentleman with history of 
swimming at a water fall presented to the emergency 
department with a history of fever and diarrhea of four 
days duration. Upon examination, he was dehydrated 
and lethargy. His vital signs revealed blood pressure 
of 120/80mmHg, heart rate of 120 beats per minute 
and temperature of 38.3 Celcius. Abdominal and 
neurologically examination was unremarkable.
His systemic examinations were unremarkable. Initial 
blood investigations shows hemoglobin 13g/dL, 
hematocrit 37%, total white blood cell 3.8 x10^9/L, 
platelet 103 x10^9/L, urea 7 mmol/L, creatinine 132 
µmol/L and creatinine kinase 800 U/L. Leptospirosis 
IgM Antibody was positive. He was diagnosed as having 
leptospirosis with acute kidney injury. Intravenous 
ceftriaxone 2 gram once daily was promptly started. 
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Fig. 1  Chest X-ray where it showed sudden and diffuse lung infiltration
On day three of admission, patient was found to be 
tachypnoeic and was intubated for impending respiratory 
collapse. Further investigation shows patient develops 
pulmonary hemorrhage as evidence by chest X-ray 
findings of bilateral diffuse alveolar space shadowing 
(Fig. 1) and the presence of fresh blood upon suctioning 
of the endotracheal tube. There was worsening of 
blood parameters with reducing platelet count and 
rapid drop of hemoglobin to 10.9 g/dL, platelet 26 
x10^9/L and total white 6.1x 10^9/L. Intravenous 
methylprednisolone 500mg once daily was started and 
continued for three days. His condition improved and he 
was extubated within one week. Repeated chest X-ray 
(Fig. 2) showed drastic improvement after intravenous 
methylprednisolone. He was discharged subsequently 
well.
DISCUSSION
Leptospirosis is one of the most prevalent zoonosis in the 
world, especially in tropical country. It is a transmissible 
disease caused by pathogenic spirochetes of the genus 
Leptospira which is present in animals’ urine such as 
mice, cows and buffaloes. Although occupational 
exposure in farm workers, pet shop owners, veterinarians 
as well as field agricultural workers accounts for 
majority of human case of leptospirosis, lately it has 
also well known to be a disease of recreation. On the 
other hand, urban dwellers may be infected through 
exposure to rat urine.  The disease can be transmitted 
through open wound, skin, and even through mucous 
membrane of the eyes and mouth, that has been in the 
contaminated water for a prolong period of time. Our 
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patient has a history of jungle trekking and swimming 
in the waterfall that makes him high risk to be infected 
with leptospirosis. The diagnosis was confirmed with 
Leptospira antibody serology. 
The symptoms of leptospirosis are usually mild in about 
90% of cases. They tend to appear suddenly about seven 
to fourteen days after infected by the leptospira bacteria. 
However, symptoms can develop as early as 2 and as 
late as 30 days after exposure. The symptoms consist of 
mild headache, myalgia, cough, loss of appetite, nausea 
and vomiting. These symptoms will resolve within 5 to 
7 days. However, about 10% of cases progress to severe 
leptospirosis, which is also called Weil’s disease. Severe 
leptospirosis usually develops one to three days after 
the milder symptoms have resolved. In severe cases 
organs such as brain, liver, kidneys, heart and lungs are 
involved.
Patients with leptospirosis may present with mainly 
respiratory symptoms and they usually develop between 
fourth and sixth day of illness. The disease deteriorates 
rapidly and may be life threatening in less than 72 hours. 
Although LPHS is not uncommon, it has a rapid and 
severe course with high mortality rates of 30-60%. 
Evidence is rather unclear for the use of corticosteroids 
in the treatment of severe leptospirosis. The rationale for 
their use in such situation is that, severe immunological 
response that is triggered can results in multi-organ 
dysfunction. Glucocorticoid-based therapy such 
as intravenous methylprednisolone can reduce the 
Fig. 2 Rapid resolution of the lung infiltration after intravenous methylprednisolone was given
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production of cytokine and TNF-α, which in turn tone 
down the inflammatory response of the disease, and 
therefore, ameliorate the adverse effect of immune-
mediated response.. In fact, there are a number of cases 
reported supports the role of methylprednisolone in 
LPHS (1).
In this case, the patient is diagnosed to have suffered from 
LPHS on third day of admission. His respiratory symptoms 
developed rapidly and intravenous corticosteroid was 
administered for a consecutive of three days duration. 
Patient responded well to intravenous corticosteroid. 
A study by Trivedi et al. showed that 61.53% of 
the pulmonary leptospirosis patients has significant 
improvement in the lung disease after receiving 
early course (within the first 12 hours) intravenous 
methylprednisolone 1 gram daily for 3 days. In the same 
study, intravenous methylprednisolone is also beneficial 
in severe cases whereby the mortality has decreased from 
85.71% to 33.33% (2).  Others studies has also concluded 
that pulmonary involvement in case of leptospirosis can 
be treated successfully with less expensive and less 
complicated interventions, which is corticosteroid (3). 
As for the dosing of methylprednisolone, many studies 
proposed that it should be given at a high dose of 1 gram 
IV daily for 3 days, followed by oral prednisolone at a 
dose of 1mg/kg/day for 7 days (4). Corticosteriods has 
been shown to reduce or delay the need for ventilator 
support and serves an important role in infrastructure 
limited settings. For our case, we are the first to report 
that usage of a much lower dose of 500mg once daily 
for 3 days without maintenance dose can equally lead to 
a full recovery from LPHS. In fact, our patient has made 
a complete and tremendous recovery from leptospirosis.
However, a recent systemic review studying the role 
of high dose corticosteroids in severe leptospirosis 
yielded mixed results. Four studies revealed a benefit of 
corticosteroids in treating severe disease with pulmonary 
involvement when administered early in the course of 
the disease, but these studies had several methodological 
limitations. Only the randomized controlled trial study 
showed that corticosteroids are ineffective and may 
increase the risk of nosocomial infections. The author 
concluded that there is no strong evidence to suggest 
that high dose corticosteroids are effective in severe 
leptospirosis, and a well-designed randomized clinical 
trial is needed to resolve this (5). Moreover, steroids 
used in LPHS carries the risk of opportunistic infections 
and adverse effects like hyperglycemia, abdominal 
discomfort, skin rash and hot flushes.
Other treatments proposed for LPHS include 
immunomodulation therapy like plasmapheresis, 
cyclophosphamide and plasma exchange. All patients 
with LPHS should be mechanically ventilated in a timely 
manner. In fact, extracorporeal membrane oxygenation 
(ECMO), a method of cardiopulmonary support which 
relieves lungs of its gas exchange function, has been 
used to be given to patients that are difficult to ventilate 
in spite of maximal mechanical ventilation.
There is limitation in our study. Our results may not 
be able applicable to a wider or different population. 
Nevertheless, the outcome from our study, allow us 
to form hypothesis that a small dose of corticosteroids 
could be one of the viable treatment options for LPHS.
CONCLUSION
Our case highlights the need for suspicion of LPHS when 
patient develop hemoptysis or respiratory distress. Early 
recognition and high suspicious of diagnosis is important 
as administration of corticosteroid in time, in addition of 
broad-spectrum antibiotics, mechanical ventilation and 
early supportive care can lead to successful treatment, 
shortened hospital stays, reduction of morbidity and 
morbidity. Targeting the vasculitic nature of the disease 
via the smallest dose of corticosteroid has demonstrated 
to be effective as evidence by our patient’s response and 
improvement to treatment. 
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